These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30019282)

  • 1. PEGylated lipid microspheres loaded with cabazitaxel for intravenous administration: stability, bioavailability, antitumor efficacy, and toxicity.
    Liu Y; Xie B; Li L; Zhang X; Zhang Y; He H; Yin T; Tang X; Cai C; Gou J
    Drug Deliv Transl Res; 2018 Oct; 8(5):1365-1379. PubMed ID: 30019282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-EGFR immunoliposomes for cabazitaxel delivery: From formulation development to in vivo evaluation in prostate cancer xenograft model.
    Carolina Cruz de Sousa A; da Silva Santos E; da Silva Moreira T; Gabriela Araújo Mendes M; Rodrigues Arruda B; de Jesus Guimarães C; de Brito Vieira Neto J; Santiago de Oliveira Y; Pedro Ayala A; Rodrigues da Costa MD; Lima Sampaio T; Paula Negreiros Nunes Alves A; Pessoa C; Petrilli R; Eloy JO
    Int J Pharm; 2024 Aug; 661():124439. PubMed ID: 38972520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluations of norcantharidin-loaded intravenous lipid microspheres with low toxicity.
    Lin X; Zhang B; Zhang K; Zhang Y; Wang J; Qi N; Yang S; He H; Tang X
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1449-62. PubMed ID: 22971185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
    Tong SW; Xiang B; Dong DW; Qi XR
    Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cabazitaxel-loaded polymeric micelle system with superior in vitro stability and long blood circulation time.
    Han X; Chen D; Sun J; Zhou J; Li D; Gong F; Shen Y
    J Biomater Sci Polym Ed; 2016; 27(7):626-42. PubMed ID: 26914063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
    Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO
    J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entrapping of Nanoparticles in Yeast Cell Wall Microparticles for Macrophage-Targeted Oral Delivery of Cabazitaxel.
    Ren T; Gou J; Sun W; Tao X; Tan X; Wang P; Zhang Y; He H; Yin T; Tang X
    Mol Pharm; 2018 Jul; 15(7):2870-2882. PubMed ID: 29863879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.
    Jun YJ; Jadhav VB; Min JH; Cui JX; Chae SW; Choi JM; Kim IS; Choi SJ; Lee HJ; Sohn YS
    Int J Pharm; 2012 Jan; 422(1-2):374-80. PubMed ID: 22079718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
    Wang L; Li M; Zhang N
    Int J Nanomedicine; 2012; 7():3281-94. PubMed ID: 22802688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stable and practical etoposide-containing intravenous long-/medium-chain triglycerides-based lipid emulsion formulation: pharmacokinetics, biodistribution, toxicity, and antitumor efficacy.
    Dong W; Zhang L; Niu Y; Fan D; Wu X; Tang X; Cai C
    Expert Opin Drug Deliv; 2013 May; 10(5):559-71. PubMed ID: 23373755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer.
    Qu N; Lee RJ; Sun Y; Cai G; Wang J; Wang M; Lu J; Meng Q; Teng L; Wang D; Teng L
    Int J Nanomedicine; 2016; 11():3451-9. PubMed ID: 27555767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Polymer Interaction, Pharmacokinetics and Antitumor Effect of PEG-PLA/Taxane Derivative TM-2 Micelles for Intravenous Drug Delivery.
    Wang Q; Liu Y; Pu C; Zhang H; Tan X; Gou J; He H; Yin T; Zhang Y; Wang Y; Tang X
    Pharm Res; 2018 Sep; 35(11):208. PubMed ID: 30215146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery.
    Shi J; Zhang J; Shen Y; Tang L; Zhao J; Tu J; Tian Y; Feng Y
    Drug Deliv; 2015 Feb; 22(2):168-81. PubMed ID: 24215124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating breast cancer metastasis with cabazitaxel-loaded polymeric micelles.
    Zhong T; He B; Cao HQ; Tan T; Hu HY; Li YP; Zhang ZW
    Acta Pharmacol Sin; 2017 Jun; 38(6):924-930. PubMed ID: 28504249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
    Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N
    Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and pharmacological evaluation of a PEG based nanoparticulate camptothecin analog for oral administration.
    Nekkanti V; Venkateswarlu V; Ansari KA; Pillai R
    Curr Drug Deliv; 2011 Nov; 8(6):661-6. PubMed ID: 22313161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.
    Jin Y; Wu Z; Li C; Zhou W; Shaw JP; Baguley BC; Liu J; Zhang W
    Pharm Res; 2018 Jan; 35(1):13. PubMed ID: 29302821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.